2012, Number 99
<< Back Next >>
Rev Enfer Infec Pediatr 2012; 25.26 (99)
Bacterial meningitis: microbiological behavior in the past 21 years in a third level pediatric hospital
Coria LJJ, Balderrabano SNA, Rosales URE, Juárez EM, Díaz CT
Language: Spanish
References: 19
Page: 101-108
PDF size: 234.68 Kb.
ABSTRACT
Despite advances in the treatment of bacterial meningitis (BM), it remains a major public health problem, since it goes
against the patient’s life, especially in developing countries.
Objective: To evaluate the epidemiological changes of the BM
in terms of microbiology in the last 21 years in children older than one month admitted to the Hospital Infantil de Mexico
Federico Gomez.
Material and Methods: We reviewed 424 medical records of patients of both sexes from 0 to 18 years
old, admitted to the hospital in the last 21 years with a diagnosis of BM, which had the following criteria: 1) cerebrospinal
fluid (CSF) with pleocytosis › 10 cells/mm
3 and a positive CSF culture or latex agglutination for
H. influenzae type b (Hib),
S. pneumoniae (S. pn) or
Neisseria meningitidis (NMN), or Gram stain positive in CSF and blood culture positive for Hib or S.
pn bacteria NMN. 2) positive culture for any agent other than the usual.
Results: From the total, only 300 patients showed
changes in CSF with a germ isolated in 83 cases, Hib remains the most important infectious agent followed by S. pn, with
46 (55.42%) and 15 (18.7%) isolates, respectively. The age group most affected was › 3 months to 2 years.
Conclusions: In
the last 21 years (1989-2010), the incidence of BM as well as associated mortality have declined significantly, however, shows
the involvement of other infectious agents.
REFERENCES
McCraken HG. Current management of bacterial meningitis in infants and children. Pediatr Infect Dis J 1992;11:169-174.
López LP, Gómez BD, Sequeira SM, Moreno MJ. Actualidades en meningitis bacteriana. Infectología 1990;10(2):75-89.
Murray CJL, López AD. Global Health Statistics. A Compendium of incidence, Prevalence and Mortality Estimates for Over Conditions. Vol II. Harvard university Press.1996.
Salih MA, Khaleefa OH, Bushara M, et al. Long term sequelae of childhood acute bacterial meningitis in a developing country. Scand J Infect Dis 1991;23:175-182.
Committee on Infectious Diseases/AAP. Therapy for Children with Invasive Pneumococcal Infections. Pediatrics 1997;99(2):289-299.
Gómez BD, Jimémez VA, Rodríguez SR. Meningitis bacteriana. Parte I. Bol Med hosp Infant Méx 1998;5(10):599-622.
Phillips FC,MD. Epidemiology of Bacterial Meningitis. Pediatr Ann 1994;23(2):67-68.
Garpenholt O, Silfverdal S, Hugosson S, et al. The impact of Haemophilus influenzae type b vaccination in Sweden. Scand J Infect Dis 1996;28:165.
Peltola H, Kilpi T, Antilla M. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunization with conjugate vaccines. Lancet 1992;340:592.
Gold R. Epidemiology of Bacterial Meningitis. Infect Dis Clin North Am 1999;13(3):515-525.
Carroll K, Carroll C. The epidemiology of bacterial meningitis in a Pacific Island population. P N G Med J 1993;36:234.
Moore PS. Meningococcal meningitis in Sub-Saharan Africa: A model for the epidemic process. Clin Infect Dis 1992;14:515.
Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the estates united in 1995. Active surveillance Team. N Engl J Med 1997;337:970.
Center for Disease control. Progress toward elimination of Haemophilus influenzae type b disease among infants and children in the United states 1987-95. MMWR 1996;45(42):901-906.
Adams WG, Deaver KA,Cochi SL, et al. Decline in childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993;269:221-226.
Heath PT, Booy R, Azzopardi HJ, Slack MP, Fogarty J, Moloney AC, et al. Non-type b Haemophilus influenzae disease: clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era. Pediat Infect Dis J 2001;20:300-5.
DiFabio J, Castañeda E, Agudelo C, De la Hoz F, Hortal M, Camou T, Echániz-Avilés G, et al. Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigía Group, 1993 to 1999. Pediat Infect Dis J 2001;20:959-967.
Kaplan SL, Mason Jr EO, Wald ER, Tan TQ, Schutze GE, Bradley JS, et al. Six year multicenter surveillance of invasive pneumococcal infections in children. Pediat Infect Dis J 2002;21:141-147.
Stovall SH, Schutze GE. Meningococcal infections in children from Arkansas. Pediat Infect Dis J 2002;21:366-370.